Matrixx Initiatives, Inc. (NASDAQ:MTXX)

CAPS Rating: 5 out of 5

The Company develops, produces, markets and sells innovative, over-the-counter healthcare products.

Recs

1
Player Avatar 7number7 (52.31) Submitted: 12/3/2006 9:06:24 PM : Outperform Start Price: $19.23 MTXX Score: -54.49

Matrix (mtxx)....great cold remedy (Zicam) with the nasal swabs...starting to market well..in all the bid stores and drug chains...getting shelf space...specualtive core holding with big upside potential.

Featured Broker Partners


Advertisement